Medical Oncologist
Your treatment timeline
How Long Will You Stay — on Enzalutamide?
Enzalutamide is not a course with a fixed end date. You take it every day for as long as it is controlling your cancer. Understanding what drives that decision — and what the stopping rules actually are — makes it easier to plan.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026
- No fixed duration — Unlike chemotherapy, enzalutamide is not given in cycles with a planned end date.
- Monitoring decides continuation — Your PSA and periodic scans tell your team whether the drug is still working.
- Side effects can be managed — Dose adjustment is possible if the standard dose becomes hard to tolerate.
- Stopping is a planned decision — When enzalutamide stops working, there are next-line options — this is a conversation your team plans for.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Enzalutamide has no fixed end date. You take it every day for as long as it is controlling your cancer and the side effects are manageable. Your team will monitor your PSA and do scans at regular intervals. Treatment continues until the cancer shows clear signs of growing again, or until a side effect cannot be managed.
Is enzalutamide a course, or do you take it indefinitely?
Enzalutamide is a continuous treatment, not a course. There is no cycle count and no scheduled end date built into the prescription.
This is one of the biggest differences from chemotherapy. Chemotherapy is given in rounds with breaks between them; enzalutamide is one tablet taken every day, for as long as it continues to work.
That can mean months or years. The drug stays effective for different periods in different people, and the only way to know how long it will work for you is to monitor it regularly.
How your team decides whether to keep going
PSA blood test
Done at regular intervals while you are stable. A stable or falling PSA tells your team the drug is working. This is the main signal between appointments.
Symptom review
At each visit you are asked about new pain, fatigue, dizziness, and any other changes. Symptoms your team did not expect can trigger an earlier scan.
Imaging when needed
Scans — CT, bone scan, or PET-CT — are ordered when PSA is rising or new symptoms appear, not at every visit. They confirm whether growth is now visible on imaging.
Dose review
If side effects are making the standard dose difficult, your oncologist may reduce it before considering stopping. Continuing on a lower dose is often possible.
Continuation decision
Based on all of the above, your team decides to continue, adjust, or transition to a different treatment. You are part of that conversation.
Words your team may use when discussing whether to stop
- PSA response
- A fall in your PSA level after starting enzalutamide. It means the drug is suppressing cancer activity, and treatment continues.
- PSA progression
- A confirmed rise in PSA on two or more successive tests, suggesting the cancer may be adapting. One rise alone is not the stopping signal.
- Radiographic progression
- New growth visible on a scan — new lesions or enlarging existing ones. This is a stronger stopping signal than a PSA change alone.
- Clinical progression
- New symptoms related to the cancer, such as new bone pain or a change in bladder function. Can prompt a review even when PSA looks stable.
- Dose modification
- Reducing the number of tablets to manage side effects while trying to keep treatment going. Ask your oncologist what dose you are on and whether adjustment is possible.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You do not have to work this out alone
A 45-minute consultation with a specialist who treats this every week.
What to track between appointments
- New or worsening bone pain — note where it is and whether it is changing day to day
- Fatigue that is limiting your day more than it did the week before
- Dizziness, lightheadedness, or any falls
- Changes in memory or concentration that others around you have noticed
- Blood pressure readings if your team has asked you to monitor at home
- Any new weakness, tingling, or swelling in your legs
What happens when enzalutamide stops working?
Resistance develops in most people eventually. When it does, the conversation moves to what comes next — not to whether anything is left.
The prostate cancer treatment pathway has options after enzalutamide. Which one is right depends on what your cancer has been exposed to previously, your general health, and what matters most to you.
Ask your oncologist now what the likely next step would be if enzalutamide stopped working. It is a reasonable question, and having an answer makes the transition easier if it comes.
Did you know?
Enzalutamide was studied in three separate groups of patients at different stages of prostate cancer — hormone-sensitive, non-metastatic castration-resistant, and metastatic castration-resistant — in trials named ENZAMET, PROSPER, and PREVAIL.
Having trial evidence across all three stages means your oncologist can draw on data that matches where you are in the journey, not a general estimate.
Source: NCCN Prostate Cancer Guidelines; ASCO; ESMO
Explore 50 more Prostate Cancer Targeted Medicines topics
Drug Deep Dive: Enzalutamide (Xtandi)
- Diet and Nutrition While on Enzalutamide
- Dizziness, Falls and Seizure Risk on Enzalutamide
- Does Enzalutamide Need a Steroid? Why It Differs From Abiraterone
- Enzalutamide (Xtandi, Bdenza, Enzamide): The Complete Patient Guide
- Enzalutamide Interactions: Blood Thinners, Statins and Seizure-Threshold Drugs
- Enzalutamide Myths: 'It's Chemotherapy', Fatigue and Loss of Masculinity
- Enzalutamide Price in India: Brand, Generic and Monthly Cost
- Enzalutamide Side Effects: The Complete List and Timeline
- Enzalutamide Success Rate and Survival: An Honest Look at the Numbers
- Enzalutamide With ADT and Other Prostate Cancer Treatments
- Enzalutamide in Elderly Patients and Those With Other Illnesses
- Enzalutamide in Non-Metastatic vs Metastatic Prostate Cancer
- Enzalutamide vs Abiraterone vs Apalutamide: Choosing an AR Inhibitor
- Fertility, Pregnancy and Contraception on Enzalutamide
- How Does Enzalutamide Work? The Androgen Receptor Signalling Inhibitor Explained
- How Long Does Enzalutamide Take to Work?
- How Long Will You Stay on Enzalutamide?
- Memory, Concentration and Blood Pressure Changes on Enzalutamide
- Severe Fatigue on Enzalutamide: The Commonest Reason Men Stop
- Taking Enzalutamide: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Enzalutamide
- When Enzalutamide Stops Working: Resistance and What Comes Next
- Who Is Eligible for Enzalutamide? Advanced and Metastatic Prostate Cancer
- Will Insurance or a Government Scheme Pay for Enzalutamide?
- Work, Travel and Daily Life on Enzalutamide
Drug Deep Dive: Abiraterone (Zytiga)
- Abiraterone (Zytiga, Abirapro, Abretone): The Complete Patient Guide
- Abiraterone Interactions: Steroids, BP Medicines and Herbal Products
- Abiraterone Myths: Steroids, Weight Gain and 'It Stops Working Fast'
- Abiraterone Price in India: Brand, Generic and Monthly Cost
- Abiraterone Side Effects: The Complete List and Timeline
- Abiraterone Success Rate and Survival: An Honest Look at the Numbers
- Abiraterone With ADT, Docetaxel and Radiation: Your Full Regimen Explained
- Abiraterone in Elderly Patients and Those With Other Illnesses
- Abiraterone in Hormone-Sensitive vs Castration-Resistant Prostate Cancer
- Abiraterone vs Enzalutamide: How to Choose in Prostate Cancer
- Diet and Nutrition While on Abiraterone
- Fatigue, Hot Flushes and Joint Pain on Abiraterone
- Fertility, Pregnancy and Contraception on Abiraterone
- How Does Abiraterone Work? The CYP17 Inhibitor Explained
- How Long Does Abiraterone Take to Work?
- How Long Will You Stay on Abiraterone?
- Liver Enzyme Rises on Abiraterone: Why the First Three Months Matter Most
- Swelling, Low Potassium and High Blood Pressure on Abiraterone
- Tests and Monitoring While You Are on Abiraterone
- When Abiraterone Stops Working: Resistance and What Comes Next
- Who Is Eligible for Abiraterone? Advanced and Metastatic Prostate Cancer
- Why Abiraterone Is Always Given With Prednisolone
- Why Abiraterone Must Be Taken on an Empty Stomach
- Will Insurance or a Government Scheme Pay for Abiraterone?
- Work, Travel and Daily Life on Abiraterone
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
Can I stop taking enzalutamide if I feel well?
Feeling well is usually a sign the drug is working, not a signal to stop. Stopping without guidance risks letting the cancer begin growing again before your team can act. If you want to stop because of side effects or for other reasons, talk to your oncologist first. There may be options — a dose adjustment, a short planned break, or switching — but that decision should be made with your team, not on your own.
Will I take enzalutamide for the rest of my life?
Some people stay on it for many years; others need to switch sooner. There is no way to know in advance how long it will remain effective for you. The goal is to stay on it for as long as it is controlling the cancer with a side-effect profile you can live with. When resistance develops, there are next-line options — so the end of enzalutamide is not the end of treatment.
What does a rising PSA mean while I am on enzalutamide?
A single PSA rise is not, on its own, a reason to stop. Your team will repeat the test to confirm the trend and may order a scan to see whether the rise corresponds to visible growth. A confirmed, sustained rise alongside radiographic progression is what usually triggers the decision to change treatment. One number at one visit is data; a pattern over time is what drives a decision.
Can the dose be reduced if side effects are difficult?
Yes. Dose modification is a recognised approach when the standard dose causes significant fatigue, dizziness, or other side effects. Your oncologist can reduce the dose and monitor whether cancer control is maintained at the lower level. This is preferable to stopping outright if the drug is otherwise working. Tell your team what you are experiencing — they cannot adjust what they do not know about.
How often will I need scans while on enzalutamide?
Scans are not done at every visit. PSA monitoring handles the routine check; imaging is ordered when PSA shows a concerning trend, when new symptoms appear, or at intervals your oncologist sets based on your stage and history. Ask your team when your next scan is planned and what PSA pattern would trigger one earlier, so you know what to watch for between appointments.
What are the options if enzalutamide stops working?
The options depend on what treatments you have already had, your general health, and the pattern of how your cancer is progressing. The prostate cancer pathway includes other agents that work on the androgen receptor pathway, chemotherapy, radiopharmaceuticals, and in some cases clinical trials. Your oncologist will have considered this when planning your treatment. You do not need to wait for enzalutamide to fail before asking what comes next — that conversation is one worth having now.